
Journal of Heterocyclic Chemistry p. 845 - 851 (1997)
Update date:2022-08-05
Topics: Optimization Retrosynthetic analysis Purification and characterization Scale-up Safety Precautions Publication and Patenting Protection and Deprotection Final Characterization Reagents and Conditions
Biagi, Giuliana
Giorgi, Irene
Livi, Oreste
Manera, Clementina
Scartoni, Valerio
Barili, Pier Luigi
This paper continues the synthesis of new 1,2,3-triazolo[1,2-a]benzotriazoles or 2,3-benzo-1,3a,6,6a-tetrazapentalenes to submit to biological assays. The derivatives were obtained by deoxycyclization reactions of appropriate nitrophenyl-1,2,3-triazole derivatives and by thermal decomposition of appropriate azidophenyl-1,2,3-triazoles (Schemes 1 and 2). Some attempts to extend these synthetic routes to the preparation of 1,2,4-triazolo[1,2-a]benzotriazoles (Scheme 3) and 1,2,3-triazolo[1,2-b]-4H-1,2,3-benzo-triazines (Scheme 4) completely failed.
View MoreWuxi Innopal International Trade CO.,LTD
Contact:+86-510-80711901-8003
Address:Room 402,Building 5,Longze Garden,No.17,South huanjiu Road,Yixing City, Jiangsu,China
Jinan Hongfangde Pharmatech Co.,Ltd
Contact:86-531-88870908
Address:F Bldg. West Unit North Area of Univ. Tech. Garden Xinyu Rd. Jinan New & High Tech Industry Development Zone Shandong, China
SuZhou Ascepion Pharmaceuticals, Inc.(expird)
Contact:0512-86881668
Address:Building C,68Xingqing Road,Suzhou,China.
ShangHai Ruiyi Medical Technology Co.,Ltd.
Contact:+86-21-54718086
Address:No951 Jianchuan RD,Minhang District
Contact:021
Address:Pudong
Doi:10.1016/S0040-4020(97)00625-X
(1997)Doi:10.3390/molecules25173993
(2020)Doi:10.1016/S0040-4039(97)01156-8
(1997)Doi:10.1016/0960-894X(95)00563-9
(1996)Doi:10.1021/jo9707085
(1997)Doi:10.1039/a700987i
(1997)